|
|
Volumn 60, Issue 6, 2011, Pages 1309-1310
|
|
Antihypertensive drugs and the risk of prostate cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ADULT;
AGED;
ANTIHYPERTENSIVE THERAPY;
CANCER DIAGNOSIS;
CANCER GRADING;
CANCER GROWTH;
CANCER RISK;
DRUG USE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
PROSTATE CANCER;
AGED;
AGED, 80 AND OVER;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BIOPSY;
CHI-SQUARE DISTRIBUTION;
HUMANS;
INCIDENCE;
MALE;
MIDDLE AGED;
PROPORTIONAL HAZARDS MODELS;
PROSTATIC NEOPLASMS;
RISK ASSESSMENT;
RISK FACTORS;
SPAIN;
|
|
EID: 80255137438
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2011.09.009 Document Type: Letter |
|
Times cited : (1)
|
|
References (5)
|
